Personal information
Biography
Brenda has a degree in Biomedical Sciences at Grande Rio University (2019) and Masters in Pharmacology and Medicinal Chemistry (2022) at the Federal University of Rio de Janeiro (UFRJ) . Currently is a PhD student at the Pharmacology and Medicinal Chemistry program of UFRJ woking with new α7 nicotinic receptor drug candidates for the treatment of schizophrenia. Brenda has experience in neuropharmacology, cognitive neuroscience, animal models of schizophrenia and behavioral tasks.